XML 32 R22.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholders' Equity
 6 Months Ended
Apr. 30, 2025
Equity [Abstract]  
Stockholders' Equity Stockholders' Equity
The components of accumulated other comprehensive loss, net of taxes as of April 30, 2025, and changes for the six months ended April 30, 2025 were as follows:
Net unrealized gains (losses)
on
available-for-sale
securities		Net unrealized (losses) gains
on cash
flow hedges		Unrealized
components
of defined
benefit plans		Cumulative
translation
adjustment		Accumulated
other
comprehensive
loss
 In millions
Balance at beginning of period$8 $(16)$(2,342)$(627)$(2,977)
Other comprehensive loss before reclassifications(6)(195)(20)(12)(233)
Reclassifications of losses into earnings— 31 62 — 93 
Tax benefit (provision) — 30 (6)(1)23 
Balance at end of period$2 $(150)$(2,306)$(640)$(3,094)
The components of accumulated other comprehensive loss, net of taxes as of April 30, 2024, and changes for the six months ended April 30, 2024 were as follows:
 Net unrealized
 gains on
available-for-sale
securities		Net unrealized
gains (losses)
on cash
flow hedges		Unrealized
components
of defined
benefit plans		Cumulative
translation
adjustment		Accumulated
other
comprehensive
loss
 In millions
Balance at beginning of period$— $61 $(2,507)$(638)$(3,084)
Other comprehensive income (loss) before reclassifications3 (35)(1)(8)(41)
Reclassifications of (gains) losses into earnings— (1)69 — 68 
Tax benefit (provision)— 6 (8)1 (1)
Balance at end of period$3 $31 $(2,447)$(645)$(3,058)
Share Repurchase Program
For the six months ended April 30, 2025, the Company repurchased and settled 5.7 million shares under its share repurchase program through open market repurchases, which included 0.1 million shares that were unsettled open market repurchases as of October 31, 2024. As of April 30, 2025, the Company did not have any unsettled open market repurchases. Shares repurchased for the six months ended April 30, 2025 were recorded as a $100 million reduction to stockholders' equity. As of April 30, 2025, the Company had a remaining authorization of approximately $0.7 billion for future share repurchases.